Concepedia

Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: Nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1

Nicola Duffy, Brian D. Green, Nigel Irwin, Victor A. Gault, Aine McKillop, Finbarr O’Harte, Peter R. Flatt

European Journal of Pharmacology · 2007 · 50 citations · 33 references

DOI

Concepts

References

33

Oral Antidiabetic Agents

Andrew J. Krentz, Clifford J. Bailey · Drugs · 2005 · 1.1K citations

Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes

Bo Åhrén, Ramón Gomis, Eberhard Standl et al. · Diabetes Care · 2004 · 488 citations · Full text

, , +17

Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes

Bo Åhrén, Erik Simonsson, Hillevi Larsson et al. · Diabetes Care · 2002 · 423 citations · Full text

, , +15

Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice

Peter R. Flatt, Clifford J. Bailey · Diabetologia · 1981 · 407 citations · Full text

, , +16

Characterization of a Novel Glucose-Responsive Insulin-Secreting Cell Line, BRIN-BD11, Produced by Electrofusion

Neville H. McClenaghan, Christopher R. Barnett, Eric Ah-Sing et al. · Diabetes · 1996 · 345 citations

, , +17